Myriad Genetics Inc (NASDAQ:MYGN)

19.16
Delayed Data
As of Nov 29
 +0.31 / +1.64%
Today’s Change
15.38
Today|||52-Week Range
28.45
-30.58%
Year-to-Date
Largest transactions by value over  
NameTypeDateShares
traded
Share
price
Transaction
value
Since
transaction
Diaz Paul J
President & Chief Executive Officer
Sale8/13/202249,980$27.61$1.4M-31.24%
Diaz Paul J
President & Chief Executive Officer
Sale3/24/202226,200$25.32$663.4K-24.29%
Diaz Paul J
President & Chief Executive Officer
Sale8/13/202222,370$27.61$617.6K-31.24%
Diaz Paul J
President & Chief Executive Officer
Sale3/24/202217,884$25.32$452.8K-24.29%
Riggsbee R Bryan
Chief Financial Officer
Sale2/18/202211,180$25.69$287.2K-25.38%
Hart Jayne B
Chief People Officer
Sale2/28/20227,000$25.00$175.0K-21.37%
Hart Jayne B
Chief People Officer
Buy2/28/20227,000$23.98$167.9K-21.37%
Riggsbee R Bryan
Chief Financial Officer
Sale10/09/20227,411$19.62$145.4K+1.11%
Lambert Nicole
Chief Operating Officer
Sale10/09/20227,251$19.62$142.3K+1.11%
Riggsbee R Bryan
Chief Financial Officer
Sale3/24/20225,323$25.32$134.8K-24.29%
Page of 9